IQVIA Named to FORTUNE's 2022 List of “World's Most Admired Companies,” Ranked #1 in Health Care: Pharmacy and Other ServicesBusiness Wire • 02/02/22
IQVIA to Announce Fourth-Quarter and Full-Year 2021 Results on February 15, 2022Business Wire • 02/01/22
Global Medicine Spending to Reach $1.8 Trillion in 2026, Including Spending on COVID-19 Vaccines, According to Study by the IQVIA Institute for Human Data ScienceBusiness Wire • 12/09/21
IQVIA Decentralized Trial Suite Launches Mobile Research Nursing and Phlebotomy Services UnitBusiness Wire • 12/02/21
IQVIA Recognized as a Leader in BPO Solutions for Pharmaceutical Sales and MarketingBusiness Wire • 12/01/21
IQVIA Launches New Grants/Funding Management Module for Its Orchestrated Customer Engagement PlatformBusiness Wire • 11/18/21
IQVIA Holdings, Inc. (IQV) CEO Ari Bousbib on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/21/21
IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/12/21
IQVIA Announces Opening of New Q2 Solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded CapabilitiesBusiness Wire • 10/06/21
Polpharma Selects IQVIA's Orchestrated Customer Engagement Platform to Improve Salesforce ProductivityBusiness Wire • 09/30/21
IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 TreatmentBusiness Wire • 09/13/21
IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World DataBusiness Wire • 09/08/21